NDC Code | 43742-2123-1 |
Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-2123-1) |
Product NDC | 43742-2123 |
Product Type Name | HUMAN OTC DRUG |
Proprietary Name | Vir Combination |
Non-Proprietary Name | Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 Dna, Herpes Simplex Virus 2 Dna, Epstein-barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Influenzinum (2022-2023) |
Dosage Form | LIQUID |
Usage | ORAL |
Start Marketing Date | 20240125 |
End Marketing Date | 20290320 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Manufacturer | Deseret Biologicals, Inc. |
Substance Name | HEPATITIS B VIRUS; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
Strength | 33; 12; 12; 12; 16; 18; 15; 12; 12; 12; 12 |
Strength Unit | [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharmacy Classes | Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient] |